<?xml version="1.0" encoding="UTF-8"?>	<item><status>past</status><description>&lt;p&gt;&lt;span style="color : #000000"&gt;&lt;strong&gt;MIT Enterprise Forum Healthcare &amp;amp; Life Science SIG Event: From Startup Entrance to Strategic Exit: Building &amp;amp; Realizing Value&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="color : #704525"&gt;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="color : #704525"&gt;When: April 12, 2012 (Registration, Refreshments, and Networking 5:30-6:30PM; Program 6:30-8:00PM)&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="color : #704525"&gt;Where: UK Trade &amp;amp; Investment, 7th Floor, One Broadway, Cambridge, MA 02142&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="color : #704525"&gt;Register: &lt;a target="_blank" style="color : #3366ff ; text-decoration : underline"&gt;http://www.mitforumcambridge.org/events/healthcare-life-science-sig-event-from-startup-entrance-to-strategic-exit-building-realizing-value/&lt;/a&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="color : #704525"&gt;&lt;span&gt;As life science entrepreneurs build value moving from concept to strategy and then execution, creating a pathway to a potential exit with a strategic partner is challenging, especially since most of the entrepreneur's energy and focus is on execution and value creation. Identifying potential corporate acquirers may seem like a simple exercise - but developing the right awareness and working relationships leading to value-maximizing partnerships or exits is one of the most difficult aspects of building a new business. "From Startup Entrance to Strategic Exit" will outline key considerations and practical tips on the funding perspectives of some strategic corporate concerns and on the process necessary to build mutual value resulting in a successful exit.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;em&gt;Panelists:&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Bill Gruber - President and CEO, Solace Therapeutics (current) - former President &amp;amp; CEO, Interlace Therapeutics&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Tom Umbel - Senior Vice President, Business Development, Hologic Corporation&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Val Livada, Ph.D, MALD - Founder, Weybridge Partners and Senior Lecturer at the Sloane School of Management&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;em&gt;Moderator:&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Larry Wittenberg, JD - Partner, Co-Chair of Technology &amp;amp; Life Sciences Companies Major Practice Group, at Goodwin Procter LLP&lt;/span&gt;&lt;/p&gt;
 &lt;br /&gt;
 &lt;br /&gt;</description><event_hosts><event_hosts_item><member_name>Joshua Lang</member_name><member_id>3926861</member_id></event_hosts_item></event_hosts><maybe_rsvp_count>0</maybe_rsvp_count><waitlist_count>0</waitlist_count><updated>1334271729000</updated><rating><average>0.0</average><count>0</count></rating><group><who>Scientific Members</who><join_mode>open</join_mode><urlname>nexusproject</urlname><id>1294865</id><group_lat>42.3699989319</group_lat><group_lon>-71.0999984741</group_lon><name>Nexus Project</name></group><yes_rsvp_count>2</yes_rsvp_count><created>1333501903000</created><visibility>public</visibility><name>From Startup Entrance to Strategic Exit: Building &amp; Realizing Value</name><id>59155642</id><headcount>0</headcount><utc_offset>-14400000</utc_offset><time>1334266200000</time><event_url>http://www.meetup.com/nexusproject/events/59155642/</event_url></item>